-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Articles by Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

ByAndrew Whelton,John G. Fort,Joseph A. Puma,Diane Normandin,Alfonso E. Bello,Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

October 1st 2002

Latest Updated Articles

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
October 1st 2002

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned